CINCINNATI, Nov. 6 Kendle (Nasdaq: KNDL) todayannounced it has been named a "Best Place to Work" in Greater Cincinnati bythe Cincinnati Business Courier in the "Grand" company category amongfirst-time participants. Winners were announced today at the GreaterCincinnati Best Places to Work luncheon.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )
"Kendle is proud to be recognized as an employer of choice," said CandaceKendle, PharmD, Chairman and CEO. "Our tremendous growth and success in recentyears is a result of their unwavering passion in working to bring newmedicines to market to save and enhance the lives of people across the world.We value the contributions of our associates and work hard to create astimulating and rewarding culture that engages them through ongoing learningand career development opportunities to advance their skills and acceleratetheir careers."
Greater Cincinnati's Best Places to Work were chosen based on scores fromemployee surveys which measured employee engagement, trust in management andcoworkers, belief in career path, commitment to professional development,satisfaction with compensation and benefits as well as overall employeeworkplace fulfillment. Results were analyzed by an independent researchcompany to determine winners in four categories; small-, medium-, large- andgrand-sized businesses.
More than 100 companies participated in the Greater Cincinnati's BestPlaces to Work 2008 survey. The awards program is open to any company basedin the 15-county Greater Cincinnati region with 10 or more employees andcompanies not based here but which have at least 75 local employees. Theprogram has been conducted annually by the Business Courier since 2003.
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinicalresearch organization providing the full range of early- to late-stageclinical development services for the world's biopharmaceutical industry. Ourfocus is on innovative solutions that reduce cycle times for our customers andaccelerate the delivery of life-enhancing drugs to market for the benefit ofpatients worldwide. As one of the fastest-growing global providers of PhaseI-IV services, we offer experience spanning 90 countries, along withindustry-leading patient access and retention capabilities and broadtherapeutic expertise, to meet our customers' clinical development challenges.
Kendle was recognized by FORTUNE magazine as one of the 100fastest-growing companies in the United States for 2008. The company also hasbeen recognized as "Top CRO to Work With" in the Thomson CenterWatch 2007survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leadingglobal pharmaceutical publication Scrip World Pharmaceutical News.
Additional information and investor kits are available upon request fromKendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from theCompany's Web site at www.kendle.com.
SOURCE Kendle International Inc.